Infusion Therapy Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | MedSuite | Includes: Infusion Pumps, IV Sets, Needleless Connectors, Stopcocks & Blood Transfusion Sets
- Year: 2021
- Scope: 2017-2027
- Region: Africa, Middle East, North America, Asia-Pacific, Europe, Latin America
- Pages: 282
- Published Date: 04/13/2021
- Type: MedSuite
In 2020, the global infusion therapy market size was valued at around $7.5 billion, which is a 15% decrease when compared to 2019. In spite of COVID19, the global market size is expected to increase over the forecast period and reach $11.2 billion in 2027. Currently, the majority of the global infusion therapy market share is controlled by three main companies – Becton Dickinson, B. Braun, and ICU Medical.
Infusion therapy devices represent an integral and basic component of many treatment plans. As such, the improving quality and access to healthcare worldwide stand to positively affect the global market throughout the next 6 years. Many of the global regions have large populations that currently cannot effectively access healthcare treatment. As this continues to improve, this analysis projects how the demand for infusion therapy products will impact the global market size in 2021 and beyond.
Most countries worldwide still use gravity drip infusion more often than pump-based infusion. However, this is slowly expected to shift as sales of all varieties of infusion pumps continue to grow in many regions, including Europe. Infusion pumps offer many benefits over gravity infusions, such as increased safety features and more precise control over the treatment process. The main drawbacks are higher costs and increased need for clinician training. However, as patient volumes increase, the time and money invested into increasing the total usage of pump infusion are expected to be a justifiable expense.
How Many Intravenous Sets Are Sold Globally?
Globally, there are over 5.9 billion intravenous sets sold every year, with the Asia Pacific selling the largest number of units.Intravenous (IV) sets are devices that consist of a length of tubing that is used to administer a solution directly into the patient’s veins. This is also known as infusion therapy, and it is mostly used when oral therapy is deemed not a viable option. The number of IV sets sold will increase dramatically over the next 6 years, allowing the global intravenous set market to reach over $10 billion in 2027.
How’s COVID19 Impacting The Infusion Therapy Market?
The global infusion therapy market was impacted significantly by the global COVID-19 pandemic throughout 2020. As infection rates increased around the globe, many facilities saw declines in elective procedures and certain other visits. This decreased the overall demand for basic healthcare products, including infusion therapy devices.
In particular, the market for infusion pumps was severely impacted due to many facilities restricting their budgets and not being able to justify the replacement of pre-existing pumps while the current devices were still functional. The global market is expected to continue to be affected to a lesser degree throughout 2021, and this study project the COVID19 impact based on the worst-case and best-case scenarios.
What Are the Top Infusion Therapy Companies?
Over 50% of the global infusion therapy market share is controlled by three main companies – Becton Dickinson, B. Braun, and ICU Medical.
Becton Dickinson (BD) is the leading player in the global market for infusion therapy devices. The company has been the market leader since its 2015 acquisition of CareFusion, from which it acquired all of its infusion therapy products. Becton Dickinson is involved in all of the individual infusion therapy market segments and leads the markets for IV sets and needleless connectors.
B. Braun is the second-leading competitor in the global infusion therapy device market. The company narrowly led the infusion pump segment over Becton Dickinson, and it was second overall within IV sets. B. Braun also leads the market for stopcocks by a narrow margin over BD, while holding a notable share of the needleless connector market.
ICU medical is the third-leading competitor in the global market. The company strengthened its presence in the IV therapy device market by acquiring Hospira in 2017. Currently, ICU Medical has a strong presence in the infusion pump, IV set, needleless connector, and IV stopcock device markets.
Top Infusion Therapy Companies Analyzed
Market Segmentation Summary
While this global report suite contains all global infusion therapy market data, each of the market segments is also available as a stand-alone report, MedCore. This allows you to get access to only the infusion therapy market research that you need.
- Infusion Pumps Market | Global | 2021-2027 | MedCore – The market analysis is further broken down into segments by:
- Device Type: Large Volume Pumps, Syringe Pumps, Patient-Controlled Analgesia Pumps, Electronic Ambulatory Pumps, and Disposable Ambulatory Pumps.
- IV Sets Market | Global | 2021-2027 | MedCore – The chapter contains the market analysis which is categorized by:
- Set Type: Pump Sets, Gravity Set, Extension Sets, and Secondary Sets.
- Needleless Connectors Market | Global | 2021-2027 | MedCore – The market is broken down by:
- Valve Type: Split Septum, Blunt Cannula, and Mechanical Valves;
- Stopcocks Market | Global | 2021-2027 | MedCore – The research includes an in-depth analysis of the global stopcock market;
- Blood Transfusion Sets Market | Global | 2021-2027 | MedCore – The research ONLY provides a top-level analysis of the blood transfusion set market.
Global Research Scope Summary
|Regions||North America (Canada, United States)
Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela)
Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.)
Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine)
Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates)
Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam)
Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
|Quantitative Coverage||Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.|
|Qualitative Coverage||COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.|
|Data Sources||Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.|
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
GLOBAL INFUSION THERAPY MARKETTABLE OF CONTENTS ILIST OF FIGURES IXLIST OF CHARTS XVIEXECUTIVE SUMMARY 1GLOBAL INFUSION THERAPY MARKET OVERVIEW 1COMPETITIVE ANALYSIS 4MARKET TRENDS 6MARKET DEVELOPMENTS 7MARKETS INCLUDED 8REGIONS INCLUDED 9VERSION HISTORY 10RESEARCH METHODOLOGY 11Step 1: Project Initiation & Team Selection 11Step 2: Prepare Data Systems and Perform Secondary Research 14Step 3: Preparation for Interviews & Questionnaire Design 16Step 4: Performing Primary Research 17Step 5: Research Analysis: Establishing Baseline Estimates 19Step 6: Market Forecast and Analysis 20Step 7: Identify Strategic Opportunities 22Step 8: Final Review and Market Release 23Step 9: Customer Feedback and Market Monitoring 24
IMPACT OF COVID-19 ON THE GLOBAL INFUSION THERAPY MARKET2.1 INTRODUCTION 252.2 REGIONAL PROFILES 282.3 ANALYSIS BY MARKET SEGMENT 312.3.1 Worst Case Scenario 312.3.2 Base Case Scenario 322.3.3 Best Case Scenario 33
DISEASE OVERVIEW3.1.1 Congestive Heart Failure 353.1.2 Crohn’s Disease 363.1.3 Hemophilia 373.1.4 Immune Deficiencies 383.1.5 Multiple Sclerosis 383.1.6 Cancer 39
PRODUCT ASSESSMENT4.1 INTRODUCTION 424.2 PRODUCT PORTFOLIOS 424.2.1 Large Volume Infusion Pump 424.2.2 Syringe Pumps 444.2.3 Patient-Controlled Analgesia Pumps 464.2.4 Electronic Ambulatory Pumps 484.2.5 Disposable Ambulatory Infusion Pump 504.2.6 Intravenous Sets 5220.127.116.11 Pump Sets 518.104.22.168 Gravity Sets 522.214.171.124 Secondary Sets 5126.96.36.199 Extension Sets 524.2.7 Needleless Connectors 5188.8.131.52 Split Septum and Blunt Cannula 5184.108.40.206 Mechanical Valves 5220.127.116.11 Negative Displacement Mechanical Valves 518.104.22.168 Positive Displacement Mechanical Valves 522.214.171.124 Neutral Displacement Mechanical Valves 5126.96.36.199 Anti-Reflux Neutral Displacement Mechanical Valves 5188.8.131.52 Antimicrobial Needleless Connectors 564.2.8 Stopcocks 574.2.9 Intravenous Filters 584.2.10 Blood Transfusion Devices 5184.108.40.206 Blood Transfusion Sets 5220.127.116.11 Blood Warmers 604.3 REGULATORY ISSUES AND RECALLS 624.3.1 Argon Medical Devices 618.104.22.168 Stopcocks 624.3.2 Baxter 622.214.171.124 Infusion Pump 6126.96.36.199 Intravenous Sets 6188.8.131.52 Needleless Connectors 6184.108.40.206 Blood Transfusion Devices 664.3.3 Becton Dickinson 6220.127.116.11 Intravenous Sets 618.104.22.168 Infusion Pumps 684.3.4 Fresenius 622.214.171.124 Infusion Pumps 684.3.5 ICU Medical 6126.96.36.199 Infusion Pumps 6188.8.131.52 Intravenous Sets 694.3.6 Medtronic 7184.108.40.206 Intravenous Sets 714.3.7 MOOG Corporation 7220.127.116.11 Intravenous Sets 724.3.8 Smiths Medical 718.104.22.168 Infusion Pump 722.214.171.124 Intravenous Sets 7126.96.36.199 Stopcocks 754.3.9 Vygon USA 7188.8.131.52 Intravenous Sets 7184.108.40.206 Stopcocks 764.3.10 Zyno Medical Products 7220.127.116.11 Intravenous Sets 774.4 CLINICAL TRIALS 784.4.1 Careggi Hospital 794.4.2 Jeffrey N. Bruce 794.4.3 Johaan Wolfgang Goethe University Hospital 804.4.4 Mahidol University 804.4.5 Medallion Therapeutics, Inc. 814.4.6 Memorial Sloan Kettering Cancer Center 824.4.7 Michael J Cavnar, MD 834.4.8 National Cancer Institute 844.4.9 Octapharma 854.4.10 Xiangya Hospital of Central South University 864.4.11 Yonsei University 86
GLOBAL INFUSION THERAPY DEVICE MARKET OVERVIEW5.1 INTRODUCTION 885.2 MARKET OVERVIEW & TREND ANALYSIS 905.2.1 By Segment 905.2.2 By Region 935.3 DRIVERS AND LIMITERS 965.3.1 Market Drivers 965.3.2 Market Limiters 985.4 COMPETITIVE MARKET SHARE ANALYSIS 1005.5 MERGERS AND ACQUISITIONS 1075.6 COMPANY PROFILES 1095.6.1 Avanos Medical 1095.6.2 Baxter 1105.6.3 B. Braun 1115.6.4 Becton Dickinson 1125.6.5 ICU Medical 1145.6.6 Smiths Medical 1155.7 SWOT ANALYSIS 1165.7.1 Avanos Medical 1175.7.2 Baxter 1185.7.3 B. Braun 1195.7.4 Becton Dickinson 1205.7.5 ICU Medical 1215.7.6 Smiths Medical 122
INFUSION PUMP MARKET6.1 EXECUTIVE SUMMARY 1236.1.1 Global Infusion Pump Market Overview 1236.1.2 Competitive Analysis 1266.1.3 Markets Included 1276.1.4 Regions Included 1286.2 INTRODUCTION 1306.3 MARKET OVERVIEW 1316.3.1 By Segment 1326.3.2 By Region 1346.4 MARKET ANALYSIS AND FORECAST 1366.4.1 Large Volume Infusion Pump Market 1366.4.2 Syringe Infusion Pump Market 1426.4.3 Patient-Controlled Analgesia Infusion Pump Market 1486.4.4 Electronic Ambulatory Infusion Pump Market 1536.4.5 Disposable Ambulatory Infusion Pump Market 1586.5 DRIVERS AND LIMITERS 1626.5.1 Market Drivers 1626.5.2 Market Limiters 1646.6 COMPETITIVE MARKET SHARE ANALYSIS 166
INTRAVENOUS SET MARKET7.1 EXECUTIVE SUMMARY 1737.1.1 Global Intravenous Set Market Overview 1737.1.2 Competitive Analysis 1767.1.3 Markets Included 1777.1.4 Regions Included 1787.2 INTRODUCTION 1807.3 MARKET OVERVIEW 1817.3.1 By Segment 1817.3.2 By Region 1847.4 MARKET ANALYSIS AND FORECAST 1867.4.1 Pump Set Market 1867.4.2 Gravity Set Market 1917.4.3 Extension Set Market 1957.4.4 Secondary Set Market 1997.5 DRIVERS AND LIMITERS 2037.5.1 Market Drivers 2037.5.2 Market Limiters 2047.6 COMPETITIVE MARKET SHARE ANALYSIS 205
NEEDLELESS CONNECTOR MARKET8.1 EXECUTIVE SUMMARY 2108.1.1 Global Needleless Connector Market Overview 2108.1.2 Competitive Analysis 2138.1.3 Markets Included 2148.1.4 Regions Included 2158.2 INTRODUCTION 2178.3 MARKET OVERVIEW 2198.3.1 By Segment 2218.3.2 By Region 2238.4 MARKET ANALYSIS AND FORECAST 2258.4.1 Total Needleless Connector Market 2258.4.2 Split Septum and Blunt Cannula Needleless Connector Market 2308.4.3 Mechanical Valve Needleless Connector Market 2358.5 DRIVERS AND LIMITERS 2408.5.1 Market Drivers 2408.5.2 Market Limiters 2418.6 COMPETITIVE MARKET SHARE ANALYSIS 243
STOPCOCK MARKET9.1 EXECUTIVE SUMMARY 2489.1.1 Global Stopcock Market Overview 2489.1.2 Competitive Analysis 2519.1.3 Regions Included 2529.2 INTRODUCTION 2549.3 MARKET ANALYSIS AND FORECAST 2559.4 DRIVERS AND LIMITERS 2619.4.1 Market Drivers 2619.4.2 Market Limiters 2629.5 COMPETITIVE MARKET SHARE ANALYSIS 263
BLOOD TRANSFUSION SET MARKET10.1 EXECUTIVE SUMMARY 26810.1.1 Global Blood Transfusion Set Market Overview 26810.1.2 Regions Included 27110.2 INTRODUCTION 27310.3 MARKET ANALYSIS AND FORECAST 27410.4 DRIVERS AND LIMITERS 28010.4.1 Market Drivers 28010.4.2 Market Limiters 281
Top Infusion Therapy Companies Analyzed
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.